|
G |
Pgr |
progesterone receptor |
multiple interactions |
ISO |
erucyl amide binds to and results in decreased activity of PGR protein |
CTD |
PMID:27633901 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases activity |
ISO |
linoleamide analog results in increased activity of PPARG protein |
CTD |
PMID:29288688 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
oleylamide binds to and results in increased activity of AHR protein |
CTD |
PMID:27633901 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP3 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Chat |
choline O-acetyltransferase |
increases activity |
ISO |
oleylamide results in increased activity of CHAT protein |
CTD |
PMID:12843655 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases secretion |
ISO |
oleylamide results in decreased secretion of COL1A1 protein |
CTD |
PMID:16475185 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
decreases response to substance |
ISO |
GABRB3 gene mutant form results in decreased susceptibility to oleylamide |
CTD |
PMID:11742254 |
|
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
multiple interactions |
ISO |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP3 protein]]; oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
multiple interactions |
ISO |
oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP3 protein]]; oleylamide inhibits the reaction [[GJB1 protein co-treated with GJB2 protein] promotes the reaction [Cisplatin results in increased activity of CASP9 protein]] |
CTD |
PMID:23747833 |
|
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases activity |
ISO |
oleylamide analog results in increased activity of PPARG protein |
CTD |
PMID:29288688 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
decreases activity multiple interactions |
EXP ISO |
propionamide analog results in decreased activity of EPHX1 protein [propionamide analog results in decreased activity of EPHX1 protein] which results in increased glutathionylation of naphthalene |
CTD |
PMID:18363382 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|